Given that systemic inflammation plays a vital role in cancer‐associated cachexia as well as in insulin resistance‐related lipid accumulation in muscle,1, 29 cachectic patients were subdivided into two subgroups: cachexia with inflammation and cachexia without inflammation, using a cut‐off value of C‐reactive protein (CRP) of 10 mg/L. The gene discussed is CRP; the disease is Cachexia.